Literature DB >> 11457829

The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

M Gómez-Gonzalo1, M Carretero, J Rullas, E Lara-Pezzi, J Aramburu, B Berkhout, J Alcamí, M López-Cabrera.   

Abstract

Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus type-1 (HIV-1) is relatively common. However, the impact of this co-infection on the clinical outcome of HIV infection has not been elucidated. We herein demonstrate that the HBV X protein (HBx) superinduces ongoing HIV-1 replication and HIV-1 long terminal repeat (LTR) transcription by synergizing with Tat protein and with T-cell activation signals. Although HBx cooperated with mitogenic stimuli in the induction of reporter plasmids harboring the HIV-1 kappaB enhancer, in both a NF-kappaB-dependent manner and a NF-AT-dependent manner, deletion of this element from the LTR did not affect the HBx-mediated up-regulation in the presence of Tat and/or mitogens. In contrast, mutation of the proximal LTR Sp1-binding sites abolished the HBx-mediated synergistic activation, but only when it was accompanied by deletion of the kappaB enhancer. When HBx was targeted to the nucleus, its ability to synergize with cellular activation stimuli was maintained. Furthermore, mutations of HBx affecting its interaction with the basal transcription machinery abrogated the synergistic activation by HBx, suggesting that this protein exerts its function by acting as a nuclear co-activator. These results indicate that HBx could contribute to a faster progression to AIDS in HBV-HIV co-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457829     DOI: 10.1074/jbc.M103020200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Authors:  Helen M Chun; Mollie P Roediger; Katherine Huppler Hullsiek; Chloe L Thio; Brian K Agan; William P Bradley; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Glenn Wortmann; Nancy F Crum-Cianflone; Jason D Maguire; Michael L Landrum
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.

Authors:  Namita Kumari; Sergey Iordanskiy; Dmytro Kovalskyy; Denitra Breuer; Xiaomei Niu; Xionghao Lin; Min Xu; Konstantin Gavrilenko; Fatah Kashanchi; Subhash Dhawan; Sergei Nekhai
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

3.  Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments.

Authors:  Tim van Opijnen; Maarten C Boerlijst; Ben Berkhout
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.

Authors:  David M Iser; Nadia Warner; Peter A Revill; Ajantha Solomon; Fiona Wightman; Suha Saleh; Megan Crane; Paul U Cameron; Scott Bowden; Tin Nguyen; Cândida F Pereira; Paul V Desmond; Stephen A Locarnini; Sharon R Lewin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

6.  The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Authors:  Ignacio Benedicto; Francisca Molina-Jiménez; Birke Bartosch; François-Loïc Cosset; Dimitri Lavillette; Jesús Prieto; Ricardo Moreno-Otero; Agustín Valenzuela-Fernández; Rafael Aldabe; Manuel López-Cabrera; Pedro L Majano
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

Review 7.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

8.  Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.

Authors:  Sharroya Charles; Tatyana Ammosova; Jessica Cardenas; Altreisha Foster; Jamie Rotimi; Marina Jerebtsova; Abisola A Ayodeji; Xiaomei Niu; Patricio E Ray; Victor R Gordeuk; Fatah Kashanchi; Sergei Nekhai
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

9.  Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation.

Authors:  Yutao Yan; Guillaume Dalmasso; Hang Thi Thu Nguyen; Tracy S Obertone; Laetitia Charrier-Hisamuddin; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

10.  Ste20-related proline/alanine-rich kinase (SPAK) regulated transcriptionally by hyperosmolarity is involved in intestinal barrier function.

Authors:  Yutao Yan; Guillaume Dalmasso; Hang Thi Thu Nguyen; Tracy S Obertone; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2009-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.